SCHEMBL642416

SCHEMBL642416

CC(O)c1cnccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27977561 1.00
SCHEMBL681871 0.80
SCHEMBL29738290 0.80
SCHEMBL4264233 0.80
SCHEMBL28136030 0.79 SMN1; SMN2 (0.40)
SCHEMBL10714528 0.77 KDM4E (0.39)
SCHEMBL8508786 0.77 KDM4E (0.43)
SCHEMBL5842338 0.76 APLNR (0.37)
SCHEMBL20738688 0.76
SCHEMBL12955046 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119161307-B Synthesis method of 1- (2-pyrazinyl) ethanol 济南悟通生物科技有限公司 2025-03-18 CN claimed
CN-119161307-A Synthesis method of 1- (2-pyrazinyl) ethanol 济南悟通生物科技有限公司 2024-12-20 CN claimed
CN-113979955-A Preparation method of heterocyclic ester compound 河南农业大学 2022-01-28 CN claimed
CN-104388490-A Method for producing chiral pyrazinyl ethanol by biological catalysis UNIV QINGDAO SCIENCE & TECHNOLOGY 2015-03-04 CN claimed
US-8143408-B2 N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain ASTRAZENECA AB (SE) 2012-03-27 US claimed
US-20100137322-A1 NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2010-06-03 US claimed
EP-2158198-A2 NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN AstraZeneca AB (SE) 2010-03-03 EP claimed
WO-2008130320-A2 NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO claimed
EP-3881048-B1 DEVICE FOR REMOVING VOLATILE ORGANIC COMPOUNDS LETAT FRANCAIS REPRESENTE PAR LE MINI DE LINTERIEUR (FR) 2026-05-06 EP disclosed
CN-119161307-B Synthesis method of 1- (2-pyrazinyl) ethanol 济南悟通生物科技有限公司 2025-03-18 CN disclosed
CN-119161307-B Synthesis method of 1- (2-pyrazinyl) ethanol 济南悟通生物科技有限公司 2025-03-18 CN disclosed
CN-119161307-B Synthesis method of 1- (2-pyrazinyl) ethanol 济南悟通生物科技有限公司 2025-03-18 CN disclosed
CN-119161307-A Synthesis method of 1- (2-pyrazinyl) ethanol 济南悟通生物科技有限公司 2024-12-20 CN disclosed
CN-119161307-A Synthesis method of 1- (2-pyrazinyl) ethanol 济南悟通生物科技有限公司 2024-12-20 CN disclosed
WO-1996013262-A1 MUSCARINE ANTAGONISTS MERCK & CO., INC. (US) 1996-05-09 WO disclosed
EP-0475214-B1 Caffeic acid derivatives and pharmaceutical compositions containing the same SUNTORY LTD (JP) 1995-06-07 EP disclosed
US-5326785-A Arteriosclerosis andn diseases of the circulatory system SUNTORY LIMITED (JP) 1994-07-05 US disclosed
US-5232941-A Therapeutic agents for diseases of the circulatory system SUNTORY LIMITED (JP) 1993-08-03 US disclosed
EP-0475214-A1 Caffeic acid derivatives and pharmaceutical compositions containing the same SUNTORY LIMITED (JP) 1992-03-18 EP disclosed
US-4638005-A ELECTRON CARRIERS IN THE PHOTOENZYMATIC PRODUCTION OF HYDROGEN AND AMMONIA THE COCA-COLA COMPANY 1987-01-20 US disclosed